On the recordJune 10, 2014
Well, you mentioned the evergreening provision in your testimony.
Source
congress.govWell, you mentioned the evergreening provision in your testimony.
Waxman raises concerns about the potential for evergreening in drug exclusivity.
Share
More from Henry Waxman